Skip to content

Influence of stellate ganglion block on postoperative anxiety in patients undergoing mastectomy

Influence of stellate ganglion block on early postoperative anxiety in patients undergoing mastectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400082015
Enrollment
Unknown
Registered
2024-03-19
Start date
2024-03-20
Completion date
Unknown
Last updated
2024-03-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative anxiety

Interventions

Sponsors

Deyang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) All diagnosed with primary breast cancer by pathological diagnosis; 2) Women aged 18 to 70 years old; 3) TNM stage I - IIIa; 4) ASA classification I--III; 5) Undergoing modified radical breast surgery; 6) No contraindications to stellate ganglion block, such as the presence of coagulation disorders, local infections, local haematomas, severe local anatomical variations, acute myocardial infarction, etc; (7) Voluntarily participate in the programme and sign an informed consent form

Exclusion criteria

Exclusion criteria: (1) Patients with ASA classification IV and above, (i.e., severe systemic disease with incapacitating conditions, including, but not limited to: cardiac function NYHA class III or above, recent onset of unstable angina pectoris, electrocardiogram-indicated myocardial ischaemia, severe reduction in cardiac ejection fraction, third-degree atrioventricular block, grade 3 hypertension, respiratory failure, severe COPD, severely impaired lung function, liver and kidney (severe loss of functional compensation, etc.); 2) Presence of contraindications to stellate ganglion block, such as the presence of coagulation disorders, local infections, local haematomas, etc.; 3) Inability to understand the study process and do not agree to conduct the study; 4) Those who are considered by the investigator to be unsuitable to participate in the study.

Design outcomes

Primary

MeasureTime frame
Anxiety score;

Secondary

MeasureTime frame
Depression score;Quality of Recovery-15;HR;Mean arterial pressure;Upper limb circumference;

Countries

China

Contacts

Public ContactZhou Dan

Deyang People's Hospital

820738783@qq.com+86 157 2960 1372

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026